Paracrine effects of stem cells in wound healing and cancer progression (review)

International Journal of Oncology

Volumn 45, Issue 6, 2014, Pages 1789-1798

  Dittmer, Jürgen ^a   Leyh, Benjamin ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Angiogenesis; Cancer stem cells; Mesenchymal stem cells; Microvesicles; Stromal cell derived factor; Vascular endothelial growth factor

Indexed keywords

ALDEHYDE DEHYDROGENASE; BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; BLEOMYCIN HYDROLASE; BRAIN DERIVED NEUROTROPHIC FACTOR; CYSTEINE RICH PROTEIN 61; INHIBIN A; INTERLEUKIN 4; NERVE GROWTH FACTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEASOME; STROMAL CELL DERIVED FACTOR 1; THROMBOSPONDIN 1; THROMBOSPONDIN 2; THYMOSIN BETA4; VASCULOTROPIN; CASPASE 3; CD133 ANTIGEN; FIBROBLAST GROWTH FACTOR 2; GALECTIN 3; NEUROPILIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROGRAMMED DEATH 1 LIGAND 1; PROSTAGLANDIN E2; PROTEIN BCL 2; SCATTER FACTOR; SOMATOMEDIN C; STAT3 PROTEIN; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR 2;

ACUTE KIDNEY FAILURE; ADULT STEM CELL; ANGIOGENESIS; APOPTOSIS; BREAST CANCER; CANCER GROWTH; CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL RENEWAL; CELL SURVIVAL; CEREBROVASCULAR ACCIDENT; COLON CANCER; ENDOTHELIUM CELL; EXOSOME; GLIOMA; HEART INFARCTION; HEART MUSCLE CELL; HEMATOPOIETIC STEM CELL; HUMAN; KIDNEY CANCER; KIDNEY INJURY; LIVER CIRRHOSIS; LUNG METASTASIS; MALIGNANT NEOPLASTIC DISEASE; MESENCHYMAL STEM CELL; NEOVASCULARIZATION (PATHOLOGY); NERVE FIBER GROWTH; NONHUMAN; OVARY CANCER; PARACRINE SIGNALING; PRIORITY JOURNAL; REVIEW; SKIN PAPILLOMA; SPINAL CORD INJURY; STEM CELL; TISSUE REPAIR; WOUND HEALING; ANIMAL; ANTIBODY SPECIFICITY; MESENCHYMAL STROMA CELL; NEOPLASM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; DISEASE COURSE; EMBRYONIC STEM CELL; ENDOTHELIAL PROGENITOR CELL; LIVER REGENERATION; MONONUCLEAR CELL; NEURAL STEM CELL; PANCREAS CANCER; PROTEIN PHOSPHORYLATION; SECRETION (PROCESS); STEM CELL TRANSPLANTATION;

ANIMALS; APOPTOSIS; HUMANS; MESENCHYMAL STROMAL CELLS; NEOPLASMS; NEOPLASTIC STEM CELLS; NEOVASCULARIZATION, PATHOLOGIC; ORGAN SPECIFICITY; PARACRINE COMMUNICATION; SIGNAL TRANSDUCTION; WOUND HEALING;

EID: 84899508957     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2385     Document Type: Review

References (122)

1. Fuchs E and Chen T: A matter of life and death: self-renewal in stem cells. EMBO Rep 14: 39-48, 2013.
2. Hsu YC and Fuchs E: A family business: stem cell progeny join the niche to regulate homeostasis. Nat Rev Mol Cell Biol 13: 103-114, 2012.
3. Chun Q and Liang LS: Stem cell research, repairing, and regeneration medicine. Int J Low Extrem Wounds 11: 180-183, 2012.
4. Fuchs Y, Brown S, Gorenc T, Rodriguez J, Fuchs E and Steller H: Sept4/ARTS regulates stem cell apoptosis and skin regeneration. Science 341: 286-289, 2013.
5. Crisostomo PR, Wang M, Markel TA, Lahm T, Abarbanell AM, Herrmann JL and Meldrum DR: Stem cell mechanisms and paracrine effects: potential in cardiac surgery. Shock 28: 375-383, 2007. (Pubitemid 47415247)
6. Friedenstein AJ, Piatetzky S II and Petrakova KV: Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol 16: 381-390, 1966.
7. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P and Hedrick MH: Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13: 4279-4295, 2002. (Pubitemid 35471185)
8. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D and Horwitz E: Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317, 2006. (Pubitemid 44269669)
9. Friedenstein AJ, Chailakhyan RK, Latsinik NV, Panasyuk AF and Keiliss-Borok IV: Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation 17: 331-340, 1974.
10. Brooke G, Cook M, Blair C, Han R, Heazlewood C, Jones B, Kambouris M, Kollar K, McTaggart S, Pelekanos R, Rice A, Rossetti T and Atkinson K: Therapeutic applications of mesenchymal stromal cells. Semin Cell Dev Biol 18: 846-858, 2007. (Pubitemid 350138458)
11. Bluguermann C, Wu L, Petrigliano F, McAllister D, Miriuka S and Evseenko DA: Novel aspects of parenchymal-mesenchymal interactions: from cell types to molecules and beyond. Cell Biochem Funct 31: 271-280, 2013.
12. Chen J, Li Y, Wang L, Zhang Z, Lu D, Lu M and Chopp M: Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32: 1005-1011, 2001. (Pubitemid 32285175)
13. Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, Kaminski N and Phinney DG: Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA 100: 8407-8411, 2003. (Pubitemid 36842558)
14. Park KS, Jung KH, Kim SH, Kim KS, Choi MR, Kim Y and Chai YG: Functional expression of ion channels in mesenchymal stem cells derived from umbilical cord vein. Stem Cells 25: 2044-2052, 2007. (Pubitemid 47258182)
15. Rojas M, Xu J, Woods CR, Mora AL, Spears W, Roman J and Brigham KL: Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 33: 145-152, 2005. (Pubitemid 41473051)
16. Baraniak PR and McDevitt TC: Stem cell paracrine actions and tissue regeneration. Regen Med 5: 121-143, 2010.
17. Kassis I, Vaknin-Dembinsky A and Karussis D: Bone marrow mesenchymal stem cells: agents of immunomodulation and neuroprotection. Curr Stem Cell Res Ther 6: 63-68, 2011.
18. Clevers H: The cancer stem cell: premises, promises and challenges. Nat Med 17: 313-319, 2011.
19. Gupta PB, Chaffer CL and Weinberg RA: Cancer stem cells: mirage or reality? Nat Med 15: 1010-1012, 2009.
20. Visvader JE and Lindeman GJ: Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8: 755-768, 2008.
21. Dittmer J and Rody A: Stem cells in breast cancer. Histol Histopathol 28: 827-838, 2013.
22. Dvorak HF: Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315: 1650-1659, 1986.
23. Kidd S, Spaeth E, Klopp A, Andreeff M, Hall B and Marini FC: The (in) auspicious role of mesenchymal stromal cells in cancer: be it friend or foe. Cytotherapy 10: 657-667, 2008.
24. Gupta PB, Fillmore CM, Jiang G, Shapira SD, Tao K, Kuperwasser C and Lander ES: Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 146: 633-644, 2011.
25. Ren G, Chen X, Dong F, Li W, Ren X, Zhang Y and Shi Y: Concise review: mesenchymal stem cells and translational medicine: emerging issues. Stem Cells Transl Med 1: 51-58, 2012.
26. Cuiffo BG and Karnoub AE: Mesenchymal stem cells in tumor development: emerging roles and concepts. Cell Adh Migr 6: 220-230, 2012.
27. Tetta C, Consiglio AL, Bruno S, Tetta E, Gatti E, Dobreva M, Cremonesi F and Camussi G: The role of microvesicles derived from mesenchymal stem cells in tissue regeneration; a dream for tendon repair? Muscles Ligaments Tendons J 2: 212-221, 2012.
28. Zimmerlin L, Park TS, Zambidis ET, Donnenberg VS and Donnenberg AD: Mesenchymal stem cell secretome and regenerative therapy after cancer. Biochimie 95: 2235-2245, 2013.
29. Paul G and Anisimov SV: The secretome of mesenchymal stem cells: Potential implications for neuroregeneration. Biochimie 95: 2246-2256, 2013.
30. Frenette PS, Pinho S, Lucas D and Scheiermann C: Mesenchymal stem cell: keystone of the hematopoietic stem cell niche and a stepping-stone for regenerative medicine. Annu Rev Immunol 31: 285-316, 2013.
31. Parekkadan B, van Poll D, Suganuma K, Carter EA, Berthiaume F, Tilles AW and Yarmush ML: Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PLoS One 2: e941, 2007.
32. Agrawal GK, Jwa NS, Lebrun MH, Job D and Rakwal R: Plant secretome: unlocking secrets of the secreted proteins. Proteomics 10: 799-827, 2010.
33. Camussi G, Deregibus MC, Bruno S, Cantaluppi V and Biancone L: Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int 78: 838-848, 2010.
34. Muralidharan-Chari V, Clancy JW, Sedgwick A and D'Souza-Schorey C: Microvesicles: mediators of extracellular communication during cancer progression. J Cell Sci 123: 1603-1611, 2010.
35. Meckes DG Jr and Raab-Traub N: Microvesicles and viral infection. J Virol 85: 12844-12854, 2011.
36. Kim HS, Choi DY, Yun SJ, Choi SM, Kang JW, Jung JW, Hwang D, Kim KP and Kim DW: Proteomic analysis of microvesicles derived from human mesenchymal stem cells. J Proteome Res 11: 839-849, 2012.
37. Collino F, Deregibus MC, Bruno S, Sterpone L, Aghemo G, Viltono L, Tetta C and Camussi G: Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PLoS One 5: e11803, 2010.
38. Yuan A, Farber EL, Rapoport AL, Tejada D, Deniskin R, Akhmedov NB and Farber DB: Transfer of microRNAs by embryonic stem cell microvesicles. PLoS One 4: e4722, 2009.
39. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ and Lotvall JO: Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9: 654-659, 2007. (Pubitemid 47214727)
40. Bruno S, Grange C, Deregibus MC, Calogero RA, Saviozzi S, Collino F, Morando L, Busca A, Falda M, Bussolati B, Tetta C and Camussi G: Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol 20: 1053-1067, 2009.
41. Gatti S, Bruno S, Deregibus MC, Sordi A, Cantaluppi V, Tetta C and Camussi G: Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrol Dial Transplant 26: 1474-1483, 2011.
42. Ratajczak J, Miekus K, Kucia M, Zhang J, Reca R, Dvorak P and Ratajczak MZ: Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia 20: 847-856, 2006.
43. Ardoin SP, Shanahan JC and Pisetsky DS: The role of microparticles in inflammation and thrombosis. Scand J Immunol 66: 159-165, 2007. (Pubitemid 47063209)
44. Huang C, Gu H, Yu Q, Manukyan MC, Poynter JA and Wang M: Sca-1+ cardiac stem cells mediate acute cardioprotection via paracrine factor SDF-1 following myocardial ischemia/reperfusion. PLoS One 6: e29246, 2011.
45. Askari AT, Unzek S, Popovic ZB, Goldman CK, Forudi F, Kiedrowski M, Rovner A, Ellis SG, Thomas JD, DiCorleto PE, Topol EJ and Penn MS: Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362: 697-703, 2003. (Pubitemid 37101067)
46. Hu X, Dai S, Wu WJ, Tan W, Zhu X, Mu J, Guo Y, Bolli R and Rokosh G: Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis. Circulation 116: 654-663, 2007. (Pubitemid 47356350)
47. Linke A, Muller P, Nurzynska D, Casarsa C, Torella D, Nascimbene A, Castaldo C, Cascapera S, Bohm M, Quaini F, Urbanek K, Leri A, Hintze TH, Kajstura J and Anversa P: Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci USA 102: 8966-8971, 2005. (Pubitemid 40881062)
48. Nesselmann C, Ma N, Bieback K, Wagner W, Ho A, Konttinen YT, Zhang H, Hinescu ME and Steinhoff G: Mesenchymal stem cells and cardiac repair. J Cell Mol Med 12: 1795-1810, 2008.
49. Noiseux N, Gnecchi M, Lopez-Ilasaca M, Zhang L, Solomon SD, Deb A, Dzau VJ and Pratt RE: Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Mol Ther 14: 840-850, 2006. (Pubitemid 44752717)
50. Uemura R, Xu M, Ahmad N and Ashraf M: Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res 98: 1414-1421, 2006. (Pubitemid 43948066)
51. Wang Y, Abarbanell AM, Herrmann JL, Weil BR, Manukyan MC, Poynter JA and Meldrum DR: TLR4 inhibits mesenchymal stem cell (MSC) STAT3 activation and thereby exerts deleterious effects on MSC-mediated cardioprotection. PLoS One 5: e14206, 2010.
52. Tang JM, Wang JN, Zhang L, Zheng F, Yang JY, Kong X, Guo LY, Chen L, Huang YZ, Wan Y and Chen SY: VEGF/SDF-1 promotes cardiac stem cell mobilization and myocardial repair in the infarcted heart. Cardiovasc Res 91: 402-411, 2011.
53. Timmers L, Lim SK, Arslan F, Armstrong JS, Hoefer IE, Doevendans PA, Piek JJ, El Oakley RM, Choo A, Lee CN, Pasterkamp G and de Kleijn DP: Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium. Stem Cell Res 1: 129-137, 2007.
54. Lai RC, Tan SS, Teh BJ, Sze SK, Arslan F, de Kleijn DP, Choo A and Lim SK: Proteolytic potential of the MSC exosome proteome: Implications for an exosome-mediated delivery of therapeutic proteasome. Int J Proteomics 2012: 971907, 2012.
55. Xu M, Uemura R, Dai Y, Wang Y, Pasha Z and Ashraf M: In vitro and in vivo effects of bone marrow stem cells on cardiac structure and function. J Mol Cell Cardiol 42: 441-448, 2007. (Pubitemid 46135600)
56. Timmers L, Lim SK, Hoefer IE, Arslan F, Lai RC, van Oorschot AA, Goumans MJ, Strijder C, Sze SK, Choo A, Piek JJ, Doevendans PA, Pasterkamp G and de Kleijn DP: Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction. Stem Cell Res 6: 206-214, 2011.
57. Gnecchi M, He H, Noiseux N, Liang OD, Zhang L, Morello F, Mu H, Melo LG, Pratt RE, Ingwall JS and Dzau VJ: Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 20: 661-669, 2006. (Pubitemid 44933310)
58. Kinnaird T, Stabile E, Burnett MS, Shou M, Lee CW, Barr S, Fuchs S and Epstein SE: Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109: 1543-1549, 2004. (Pubitemid 38420184)
59. Estrada R, Li N, Sarojini H, An J, Lee MJ and Wang E: Secretome from mesenchymal stem cells induces angiogenesis via Cyr61. J Cell Physiol 219: 563-571, 2009.
60. Ohnishi S, Sumiyoshi H, Kitamura S and Nagaya N: Mesenchymal stem cells attenuate cardiac fibroblast proliferation and collagen synthesis through paracrine actions. FEBS Lett 581: 3961-3966, 2007. (Pubitemid 47212103)
61. Xu X, Xu Z, Xu Y and Cui G: Effects of mesenchymal stem cell transplantation on extracellular matrix after myocardial infarction in rats. Coron Artery Dis 16: 245-255, 2005. (Pubitemid 40835663)
62. Cho HJ, Lee N, Lee JY, Choi YJ, Ii M, Wecker A, Jeong JO, Curry C, Qin G and Yoon YS: Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart. J Exp Med 204: 3257-3269, 2007.
63. Oshima H, Payne TR, Urish KL, Sakai T, Ling Y, Gharaibeh B, Tobita K, Keller BB, Cummins JH and Huard J: Differential myocardial infarct repair with muscle stem cells compared to myoblasts. Mol Ther 12: 1130-1141, 2005. (Pubitemid 41723047)
64. Kupatt C, Bock-Marquette I and Boekstegers P: Embryonic endothelial progenitor cell-mediated cardioprotection requires thymosin beta4. Trends Cardiovasc Med 18: 205-210, 2008.
65. Payne TR, Oshima H, Okada M, Momoi N, Tobita K, Keller BB, Peng H and Huard J: A relationship between vascular endothelial growth factor, angiogenesis, and cardiac repair after muscle stem cell transplantation into ischemic hearts. J Am Coll Cardiol 50: 1677-1684, 2007. (Pubitemid 47562673)
66. Wu G, Rana JS, Wykrzykowska J, Du Z, Ke Q, Kang P, Li J and Laham RJ: Exercise-induced expression of VEGF and salvation of myocardium in the early stage of myocardial infarction. Am J Physiol Heart Circ Physiol 296: H389-H395, 2009.
67. Ambrosio F, Wolf SL, Delitto A, Fitzgerald GK, Badylak SF, Boninger ML and Russell AJ: The emerging relationship between regenerative medicine and physical therapeutics. Phys Ther 90: 1807-1814, 2010.
68. Li TS, Cheng K, Malliaras K, Smith RR, Zhang Y, Sun B, Matsushita N, Blusztajn A, Terrovitis J, Kusuoka H, Marban L and Marban E: Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells. J Am Coll Cardiol 59: 942-953, 2012.
69. Duran JM, Makarewich CA, Sharp TE, Starosta T, Zhu F, Hoffman NE, Chiba Y, Madesh M, Berretta RM, Kubo H and Houser SR: Bone-derived stem cells repair the heart after myocardial infarction through transdifferentiation and paracrine signaling mechanisms. Circ Res 113: 539-552, 2013.
70. Horie N, Pereira MP, Niizuma K, Sun G, Keren-Gill H, Encarnacion A, Shamloo M, Hamilton SA, Jiang K, Huhn S, Palmer TD, Bliss TM and Steinberg GK: Transplanted stem cell-secreted vascular endothelial growth factor effects post-stroke recovery, inflammation, and vascular repair. Stem Cells 29: 274-285, 2011.
71. Andres RH, Horie N, Slikker W, Keren-Gill H, Zhan K, Sun G, Manley NC, Pereira MP, Sheikh LA, McMillan EL, Schaar BT, Svendsen CN, Bliss TM and Steinberg GK: Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain. Brain 134: 1777-1789, 2011.
72. Liauw J, Hoang S, Choi M, Eroglu C, Sun GH, Percy M, Wildman-Tobriner B, Bliss T, Guzman RG, Barres BA and Steinberg GK: Thrombospondins 1 and 2 are necessary for synaptic plasticity and functional recovery after stroke. J Cereb Blood Flow Metab 28: 1722-1732, 2008.
73. Lu P, Jones LL, Snyder EY and Tuszynski MH: Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp Neurol 181: 115-129, 2003. (Pubitemid 36629234)
74. Cantinieaux D, Quertainmont R, Blacher S, Rossi L, Wanet T, Noel A, Brook G, Schoenen J and Franzen R: Conditioned medium from bone marrow-derived mesenchymal stem cells improves recovery after spinal cord injury in rats: an original strategy to avoid cell transplantation. PLoS One 8: e69515, 2013.
75. Crigler L, Robey RC, Asawachaicharn A, Gaupp D and Phinney DG: Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp Neurol 198: 54-64, 2006. (Pubitemid 43243744)
76. Sallustio F, Costantino V, Cox SN, Loverre A, Divella C, Rizzi M and Schena FP: Human renal stem/progenitor cells repair tubular epithelial cell injury through TLR2-driven inhibin-A and microvesicle-shuttled decorin. Kidney Int 83: 392-403, 2013.
77. Maeshima A, Zhang YQ, Furukawa M, Naruse T and Kojima I: Hepatocyte growth factor induces branching tubulogenesis in MDCK cells by modulating the activin-follistatin system. Kidney Int 58: 1511-1522, 2000.
78. Togel F, Weiss K, Yang Y, Hu Z, Zhang P and Westenfelder C: Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol 292: F1626-1635, 2007. (Pubitemid 46701891)
79. Imberti B, Morigi M, Tomasoni S, Rota C, Corna D, Longaretti L, Rottoli D, Valsecchi F, Benigni A, Wang J, Abbate M, Zoja C and Remuzzi G: Insulin-like growth factor-1 sustains stem cell mediated renal repair. J Am Soc Nephrol 18: 2921-2928, 2007. (Pubitemid 350058399)
80. Van Koppen A, Joles JA, van Balkom BW, Lim SK, de Kleijn D, Giles RH and Verhaar MC: Human embryonic mesenchymal stem cell-derived conditioned medium rescues kidney function in rats with established chronic kidney disease. PLoS One 7: e38746, 2012.
81. Mintz PJ, Huang KW, Reebye V, Nteliopoulos G, Lai HS, Saetrom P, Kasahara N, Jensen S, Pai M, Gordon MY, Marley SB, Behan R, Spalding DR, Haoudi A, Emara MM, Nicholls J, Rossi JJ and Habib NA: Exploiting human CD34 stem cell-conditioned medium for tissue repair. Mol Ther 22: 149-159, 2014.
82. Hogaboam CM, Bone-Larson CL, Steinhauser ML, Lukacs NW, Colletti LM, Simpson KJ, Strieter RM and Kunkel SL: Novel CXCR2-dependent liver regenerative qualities of ELR-containing CXC chemokines. FASEB J 13: 1565-1574, 1999. (Pubitemid 29411790)
83. Wei J, Barr J, Kong LY, Wang Y, Wu A, Sharma AK, Gumin J, Henry V, Colman H, Priebe W, Sawaya R, Lang FF and Heimberger AB: Glioblastoma cancer-initiating cells inhibit T-cell proliferation and effector responses by the signal transducers and activators of transcription 3 pathway. Mol Cancer Ther 9: 67-78, 2010.
84. Wei J, Barr J, Kong LY, Wang Y, Wu A, Sharma AK, Gumin J, Henry V, Colman H, Sawaya R, Lang FF and Heimberger AB: Glioma-associated cancer-initiating cells induce immunosuppression. Clin Cancer Res 16: 461-473, 2010.
85. Peng W, Wang HY, Miyahara Y, Peng G and Wang RF: Tumor-associated galectin-3 modulates the function of tumor-reactive T cells. Cancer Res 68: 7228-7236, 2008.
86. Kuklinski S, Pesheva P, Heimann C, Urschel S, Gloor S, Graeber S, Herzog V, Pietsch T, Wiestler OD and Probstmeier R: Expression pattern of galectin-3 in neural tumor cell lines. J Neurosci Res 60: 45-57, 2000. (Pubitemid 30176748)
87. Bao S, Wu Q, Sathornsumetee S, Hao Y, Li Z, Hjelmeland AB, Shi Q, McLendon RE, Bigner DD and Rich JN: Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res 66: 7843-7848, 2006. (Pubitemid 44299144)
88. Oka N, Soeda A, Inagaki A, Onodera M, Maruyama H, Hara A, Kunisada T, Mori H and Iwama T: VEGF promotes tumorigenesis and angiogenesis of human glioblastoma stem cells. Biochem Biophys Res Commun 360: 553-559, 2007. (Pubitemid 47048135)
89. Folkins C, Shaked Y, Man S, Tang T, Lee CR, Zhu Z, Hoffman RM and Kerbel RS: Glioma tumor stem-like cells promote tumor angiogenesis and vasculogenesis via vascular endothelial growth factor and stromal-derived factor 1. Cancer Res 69: 7243-7551, 2009.
90. Ping YF, Yao XH, Jiang JY, Zhao LT, Yu SC, Jiang T, Lin MC, Chen JH, Wang B, Zhang R, Cui YH, Qian C, Wang J and Bian XW: The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling. J Pathol 224: 344-354, 2011.
91. Lin G, Yang R, Banie L, Wang G, Ning H, Li LC, Lue TF and Lin CS: Effects of transplantation of adipose tissue-derived stem cells on prostate tumor. Prostate 70: 1066-1173, 2010.
92. Ho IA, Toh HC, Ng WH, Teo YL, Guo CM, Hui KM and Lam PY: Human bone marrow-derived mesenchymal stem cells suppress human glioma growth through inhibition of angiogenesis. Stem Cells 31: 146-155, 2013.
93. Kong BH, Shin HD, Kim SH, Mok HS, Shim JK, Lee JH, Shin HJ, Huh YM, Kim EH, Park EK, Chang JH, Kim DS, Hong YK, Lee SJ and Kang SG: Increased in vivo angiogenic effect of glioma stromal mesenchymal stem-like cells on glioma cancer stem cells from patients with glioblastoma. Int J Oncol 42: 1754-1762, 2013.
94. Akimoto K, Kimura K, Nagano M, Takano S, To'a Salazar G, Yamashita T and Ohneda O: Umbilical cord blood-derived mesenchymal stem cells inhibit, but adipose tissue-derived mesenchymal stem cells promote, glioblastoma multiforme proliferation. Stem Cells Dev 22: 1370-1386, 2013.
95. Bussolati B, Dekel B, Azzarone B and Camussi G: Human renal cancer stem cells. Cancer Lett 338: 141-146, 2013.
96. Grange C, Tapparo M, Collino F, Vitillo L, Damasco C, Deregibus MC, Tetta C, Bussolati B and Camussi G: Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. Cancer Res 71: 5346-5356, 2011.
97. Todaro M, Alea MP, Di Stefano AB, Cammareri P, Vermeulen L, Iovino F, Tripodo C, Russo A, Gulotta G, Medema JP and Stassi G: Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 1: 389-402, 2007. (Pubitemid 47506537)
98. Francipane MG, Alea MP, Lombardo Y, Todaro M, Medema JP and Stassi G: Crucial role of interleukin-4 in the survival of colon cancer stem cells. Cancer Res 68: 4022-4025, 2008.
99. Conticello C, Pedini F, Zeuner A, Patti M, Zerilli M, Stassi G, Messina A, Peschle C and De Maria R: IL-4 protects tumor cells from anti-CD95 and chemotherapeutic agents via up-regulation of antiapoptotic proteins. J Immunol 172: 5467-5477, 2004. (Pubitemid 38542047)
100. Todaro M, Zerilli M, Ricci-Vitiani L, Bini M, Perez Alea M, Maria Florena A, Miceli L, Condorelli G, Bonventre S, Di Gesu G, De Maria R and Stassi G: Autocrine production of interleukin-4 and interleukin-10 is required for survival and growth of thyroid cancer cells. Cancer Res 66: 1491-1499, 2006. (Pubitemid 43259930)
101. Emmink BL, Verheem A, Van Houdt WJ, Steller EJ, Govaert KM, Pham TV, Piersma SR, Borel Rinkes IH, Jimenez CR and Kranenburg O: The secretome of colon cancer stem cells contains drug-metabolizing enzymes. J Proteomics 2013: 84-96, 2013.
102. Long H, Xie R, Xiang T, Zhao Z, Lin S, Liang Z, Chen Z and Zhu B: Autocrine CCL5 signaling promotes invasion and migration of CD133+ ovarian cancer stem-like cells via NF-kappaB-mediated MMP-9 upregulation. Stem Cells 30: 2309-2319, 2012.
103. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R and Weinberg RA: Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449: 557-563, 2007. (Pubitemid 47525152)
104. Dittmer J, Oerlecke I and Leyh B: Involvement of mesenchymal stem cells in breast cancer progression. In: Breast Cancer-Focusing Tumor Microenvironment, Stem Cells and Metastasis. Gunduz M and Gunduz E (eds). INTECH Open Access Publisher, Rijeka, pp247-272, 2011.
105. Liu S, Ginestier C, Ou SJ, Clouthier SG, Patel SH, Monville F, Korkaya H, Heath A, Dutcher J, Kleer CG, Jung Y, Dontu G, Taichman R and Wicha MS: Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks. Cancer Res 71: 614-624, 2011.
106. Devarajan E, Song YH, Krishnappa S and Alt E: Epithelial-mesenchymal transition in breast cancer lines is mediated through PDGF-D released by tissue-resident stem cells. Int J Cancer 131: 1023-1031, 2012.
107. Shipitsin M, Campbell LL, Argani P, Weremowicz S, Bloushtain-Qimron N, Yao J, Nikolskaya T, Serebryiskaya T, Beroukhim R, Hu M, Halushka MK, Sukumar S, Parker LM, Anderson KS, Harris LN, Garber JE, Richardson AL, Schnitt SJ, Nikolsky Y, Gelman RS and Polyak K: Molecular definition of breast tumor heterogeneity. Cancer Cell 11: 259-273, 2007. (Pubitemid 46349843)
108. Hardt O, Wild S, Oerlecke I, Hofmann K, Luo S, Wiencek Y, Kantelhardt E, Vess C, Smith GP, Schroth GP, Bosio A and Dittmer J: Highly sensitive profiling of CD44(+)/CD24(-) breast cancer stem cells by combining global mRNA amplification and next generation sequencing: Evidence for a hyperactive PI3K pathway. Cancer Lett 325: 165-174, 2012.
109. Harbeck N, Schmitt M, Meisner C, Friedel C, Untch M, Schmidt M, Sweep CG, Lisboa BW, Lux MP, Beck T, Hasmuller S, Kiechle M, Janicke F and Thomssen C: Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients. Eur J Cancer 49: 1825-1835, 2013.
110. Dellas C and Loskutoff DJ: Historical analysis of PAI-1 from its discovery to its potential role in cell motility and disease. Thromb Haemost 93: 631-640, 2005. (Pubitemid 40485397)
111. Czekay RP, Wilkins-Port CE, Higgins SP, Freytag J, Overstreet JM, Klein RM, Higgins CE, Samarakoon R and Higgins PJ: PAI-1: An integrator of cell signaling and migration. Int J Cell Biol 2011: 562481, 2011.
112. Hogan NM, Joyce MR, Murphy JM, Barry FP, O'Brien T, Kerin MJ and Dwyer RM: Impact of mesenchymal stem cell secreted PAI-1 on colon cancer cell migration and proliferation. Biochem Biophys Res Commun 435: 574-579, 2013.
113. Beck B, Driessens G, Goossens S, Youssef KK, Kuchnio A, Caauwe A, Sotiropoulou PA, Loges S, Lapouge G, Candi A, Mascre G, Drogat B, Dekoninck S, Haigh JJ, Carmeliet P and Blanpain C: A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours. Nature 478: 399-403, 2011.
114. Monzani E, Facchetti F, Galmozzi E, Corsini E, Benetti A, Cavazzin C, Gritti A, Piccinini A, Porro D, Santinami M, Invernici G, Parati E, Alessandri G and La Porta CA: Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. Eur J Cancer 43: 935-946, 2007. (Pubitemid 46366698)
115. Maeda S, Shinchi H, Kurahara H, Mataki Y, Maemura K, Sato M, Natsugoe S, Aikou T and Takao S: CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer. Br J Cancer 98: 1389-1397, 2008. (Pubitemid 351543575)
116. Romagnani P and Anders HJ: What can tubular progenitor cultures teach us about kidney regeneration? Kidney Int 83: 351-353, 2013.
117. Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C, Hamner B, Oh EY, Gaber MW, Finklestein D, Allen M, Frank A, Bayazitov IT, Zakharenko SS, Gajjar A, Davidoff A and Gilbertson RJ: A perivascular niche for brain tumor stem cells. Cancer Cell 11: 69-82, 2007. (Pubitemid 46054518)
118. Eyler CE and Rich JN: Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis. J Clin Oncol 26: 2839-2845, 2008.
119. Ghajar CM, Peinado H, Mori H, Matei IR, Evason KJ, Brazier H, Almeida D, Koller A, Hajjar KA, Stainier DY, Chen EI, Lyden D and Bissell MJ: The perivascular niche regulates breast tumour dormancy. Nat Cell Biol 15: 807-617, 2013.
120. Descot A and Oskarsson T: The molecular composition of the metastatic niche. Exp Cell Res 319: 1679-1686, 2013.
121. Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, Weinberg RA and Lander ES: Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 138: 645-659, 2009.
122. Bottos A and Bardelli A: Oncogenes and angiogenesis: a way to personalize anti-angiogenic therapy? Cell Mol Life Sci 70: 4131-4140, 2013.